Authors: GALLIGIONI E CETTO G NASCIMBEN O BUONADAONA A CRIVELLARI D MOLINO A VERONESI A GRAIFF C BARNI S PUCCETTI C FERRAZZI E RECALDIN E SAVA C SARACCHINI S SACCO C

Citation: E. Galligioni et al., HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) VS CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL (CMF) AS ADJUVANT CHEMOTHERAPY IN HIGH-RISK PREMENOPAUSAL BREAST-CANCER PATIENTS (PTS) - A PROSPECTIVE RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 84-84

Authors: SORIO R ROBIEUX I GALLIGIONI E FRESCHI A COLUSSI AM CRIVELLARI D SARACCHINI S MONFARDINI S

Citation: R. Sorio et al., PHARMACOKINETICS AND TOLERANCE OF VINORELBINE IN ELDERLY PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 33(2), 1997, pp. 301-303

Authors: VANDALEN A HEERING KJ BARAK V PERETZ T CREMASCHI A GERONI P GION M SARACCHINI S MOLINA R NAMER M STIEBER P STURGEON C LEONARD RCF EINARSSON R

Citation: A. Vandalen et al., TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES, Breast, 5(2), 1996, pp. 82-88

Authors: GION M BARIOLI P MIONE R CAPPELLI G VIGNATI G FORTUNATO A SARACCHINI S BIASIOLI R GUSLISANO M

Citation: M. Gion et al., TUMOR-MARKERS IN BREAST-CANCER FOLLOW-UP - A POTENTIALLY USEFUL PARAMETER STILL AWAITING DEFINITIVE ASSESSMENT, Annals of oncology, 6, 1995, pp. 31-35

Authors: GION M CAPPELLI G MIONE R VIGNATI G FORTUNATO A SARACCHINI S BIASIOLI R GULISANO M

Citation: M. Gion et al., VARIABILITY OF TUMOR-MARKERS IN THE FOLLOW-UP OF PATIENTS RADICALLY RESECTED FOR BREAST-CANCER, Tumor biology, 14(6), 1993, pp. 325-333